Wu Xue

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers138 papers

Sort

By YearBy Citation

Morphological, immunohistochemical, and genetic analyses of bronchiolar adenoma and its putative variants

Jinchen Shao, Jiani C Yin, Hairong Bao, Ruiying Zhao,Yuchen Han,Lei Zhu,Xue Wu, Yang Shao,Jie Zhang

The journal of pathology. Clinical research, (2021)

WOSBibtex

Mutational landscape and genetic signatures of cell-free DNA in tumour-induced osteomalacia

Nan Wu,Zhen Zhang,Xi Zhou, Hengqiang Zhao,Yue Ming,Xue Wu, Xian Zhang, Xin-Zhuang Yang, Meng Zhou, Hua Bao, Weisheng Chen, Yong Wu

Journal of cellular and molecular medicine, (2020)

WOSBibtex

Small but strong: Mutational and functional landscapes of micronuclei in cancer genomes

Xihan Guo, Xueqin Dai,Xue Wu,Neng Cao,Xu Wang

International Journal of Cancer, (2020)

Bibtex

Abstract 707: Combinatorial assessment of ctDNA release and mutational burden predicts clinical outcome from anti-PD-(L)1 therapies in non-small-cell lung cancer

Wenfeng Fang,Yuxiang Ma, Jiani C. Yin, Huaqiang Zhou, Fufeng Wang, Hua Bao, Ao Wang,Xue Wu,Shaodong Hong,Yunpeng Yang,Yan Huang,Hongyun Zhao

Clinical Trials, (2020)

Bibtex

Abstract 745: Landscape of FGFRactivating aberrations in Chinese non-small cell lung cancer

Zhen Zhou, Zichuan Liu, Qiuxiang Ou,Xue Wu, Xiaonan Wang, Yang Shao, Hongyan Liu,Yu Yang

Clinical Trials, (2020): 745-745

Bibtex

Abstract 730: Validation of a NGS-based MSI testing workflow in liquid biopsy

Xiangyuan Ma, Hua Bao, Xiaoling Tong, Zhili Chang, Xunbiao Liu, Xiuyan Zhang, Ryan S. Robetyore,Xue Wu, Yang W. Shao

Cancer Research, (2020): 730-730

Bibtex

Abstract 741: Molecular and clinicopathological characteristics of Chinese non-small cell lung cancers with ROS1 gene fusions identified by next-generation sequencing

Dongling Gao,Yuchen Han,Zhihua Zhao, Qiuxiang Ou, Xiaoling Tong, Ruiying Zhao, Nan Dong,Xue Wu,Wencai Li, Guozhong Jiang

Clinical Trials, (2020): 741-741

Bibtex

Abstract 4268: Technical validation of a NGS-based analysis pipeline for BRCA1/2 variants and large genomic rearrangements detection

Xiangyuan Ma, Hua Bao, Zhili Chang, Yong Wu, Changwan Du, Rong Gao, Yu Song, Ryan S. Robetyore,Xue Wu, Yang W. Shao

Cancer Research, (2020): 4268-4268

Bibtex

Durable Complete Response to Alectinib in a Lung Adenocarcinoma Patient With Brain Metastases and Low-Abundance EML4-ALK Variant in Liquid Biopsy: A Case Report

Yingying Zhu, Ran Jia, Yang W. Shao, Liuqing Zhu, Qiuxiang Ou, Man Yu,Xue Wu, Yanbei Zhang

Frontiers in Oncology, (2020): 1259

Bibtex

Association of Circulating Tumor DNA from the Cerebrospinal Fluid with High-Risk CNS Involvement in Patients with Diffuse Large B-Cell Lymphoma

Xiaoxiao Wang,Yan Gao,Changguo Shan,Mingyao Lai, Haixia He,Bing Bai, Li-qin Ping, Qixiang Rong, Ruyu Ai, Lei Wen, Zhaoming Zhou, Ruoying Yu

Blood, (2020): 34-34

Bibtex

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer

Jin Kang,Xu-Chao Zhang,Hua-Jun Chen,Wen-Zhao Zhong,Yang Xu,Jian Su,Qing Zhou,Hai-Yan Tu,Zhen Wang,Chong-Rui Xu,Xue-Ning Yang,Zhi-Hong Chen

Frontiers in oncology, (2020): 596937

WOSBibtex

Acquired rare recurrent EGFR mutations as mechanisms of resistance to Osimertinib in lung cancer and in silico structural modelling

Lin Lin,Qiang Lu, Ran Cao, Qiuxiang Ou, Yutong Ma, Hua Bao,Xue Wu, Yang Shao,Zhaoxia Wang, Bo Shen

American journal of cancer research, no. 11 (2020): 4005-4015

WOSBibtex

Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study

Qian Xiao,Wei Lu, Xiangxing Kong, Yang W Shao,Yeting Hu, Ao Wang, Hua Bao, Ran Cao, Kaihua Liu, Xiaonan Wang,Xue Wu,Shu Zheng

Cancer letters, (2020)

WOSBibtex

Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors

Zheng Zhao, Tao Fu, Jiyue Gao, Yang Xu,Xue Wu, Wenjuan Chen, Xuesong Li, Ruoying Yu, Yang Washington Shao, Man Li, Yu Yao

Journal of medical genetics, (2020)

WOSBibtex

Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer

Xiao-Rong Yang, Can Pi, Ruoying Yu, Xiao-Jun Fan, Xiao-Xiao Peng,Xu-Chao Zhang,Zhi-Hong Chen,Xue Wu, Yang Shao,Yi-Long Wu,Qing Zhou

Clinical & experimental metastasis, pp.1-9, (2020)

WOSBibtex

Pretreatment hemoglobin level as a predictor to evaluate the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Zhibo Zhang,Fan Zhang, Fang Yuan, Ye Li,Junxun Ma, Qiuxiang Ou,Zhefeng Liu,Bo Yang,Lijie Wang,Haitao Tao,Sujie Zhang,Xiaoyan Li

Therapeutic advances in medical oncology, (2020): 1758835920970049-1758835920970049

WOSBibtex

Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study

Lei Shi, Caihua Xu, Yutong Ma, Qiuxiang Ou,Xue Wu, Songhua Lu, Yang Shao, Renhua Guo, Jinliang Kong

ESMO open, no. 6 (2020)

WOSBibtex

Genomic characterization of metastatic lung cancers

Hui Yu, Hua Bao, Yulin Wei, Min Wu, Shuyu Wu,Xue Wu, Yang Shao,Xinmin Zhao

Journal of Clinical Oncology, (2020): 9584-9584

Bibtex

Ibrutinib-based combination therapy exhibited therapeutic benefit in newly diagnosed primary central nervous system lymphoma

Feili Chen, Diwen Pang, Hanguo Guo, Qiuxiang Ou,Xue Wu, Xinmiao Jiang, Xiaojuan Wei,Sichu Liu, Ling Huang, Zhanli Liang,Wenyu Li

Journal of Clinical Oncology, (2020): 2556-2556

Bibtex

Genomic characterization and outcome evaluation of kinome fusions in a large non-small cell lung cancer population

Fengying Wu, Sisi Liu, Qiuxiang Ou, Hua Bao,Xue Wu, Yang Shao,Caicun Zhou

Journal of Clinical Oncology, (2020): 9620-9620

Bibtex

View All

Base Info Papers Patents Projects